Stephanie has 6+ years’ experience in evidence synthesis and has worked as part of an Evidence Review Group for the National Institute for Health and Care Excellence (NICE). She brings these ‘behind the scenes’ insights to help guide the development of robust, high-quality systematic reviews for market access applications. Her expertise extends to epidemiology, treatment guidelines, burden of disease, efficacy and adverse events, meta-analysis, statistical reviewing, shared decision making, and more.
Stephanie has spent over 12 years as an academic research scientist working across in vitro, in vivo, and clinical projects. Stephanie has a PhD in Molecular Virology from the University of York and spent over 8 years as a Postdoctoral Researcher and Science Writer in Canada. She is a member of the Association of British Science Writers.
Stephanie maintains a strong research interest in oncology, immunotherapy, viruses, immunology, genomics, personalised medicine, and gene therapy to support evidence generation in cutting-edge technologies.
Stephanie has several years of experience in evidence synthesis and has worked as part of an Evidence Review Group for the National Institute for Health and Care Excellence (NICE) assessing single and multiple technology appraisals. She brings these ‘behind the scenes’ insights to help guide the development of robust, high quality systematic reviews for market access applications. Her expertise extends to epidemiology, treatment guidelines, burden of disease, efficacy and adverse events, meta-analysis, statistical reviewing, shared decision-making and more.
Stephanie has spent over 12 years as an academic research scientist working across in vitro, pre-clinical, and clinical projects. Stephanie has a Ph.D in molecular virology from the University of York, and spent over eight years as a postdoctoral researcher and science writer in Canada. She is a member of the Association of British Science Writers.
Stephanie maintains a strong research interest in cancer, immunotherapy, viruses, immunology, genomics, personalised medicine, and gene therapy to support evidence generation in cutting-edge technologies.
